ConductScience.org, home

Paper26344763

Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR.

Gabitova L and 12 others. Cell Rep, 2015. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR. Papers, record 26344763. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344763

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR.
PubMed
Journal
Cell Rep
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
2.18
iCite
Revised in PubMed
2018-12-02
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gabitova LLinara
2Restifo DDiana
3Gorin AAndrey
4Manocha KKunal
5Handorf EElizabeth
6Yang DHDong-Hua
7Cai KQKathy Q
8Klein-Szanto AJAndres J
9Cunningham DDavid
10Kratz LELisa E
11Herman GEGail E
12Golemis EAErica A
13Astsaturov IIgor

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CholesterolMajor topic
ErbB ReceptorsMajor topic
Proto-Oncogene Proteins p21(ras)Major topic
SterolsMajor topic
3-Hydroxysteroid Dehydrogenases
Animals
Cell Line, Tumor
Female
Humans
Liver X Receptors
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Orphan Nuclear Receptors
Papilloma
Signal Transduction
Skin Neoplasms
Transfection

Source PubMed

Download CSV of topics

Grants12

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 CA164205NCI NIH HHSUnited StatesR21CA164205PubMed and NIHNIH RePORTER
R01 CA63366NCI NIH HHSUnited StatesR01CA063366PubMed and NIHNIH RePORTER
R01 CA188430NCI NIH HHSUnited StatesR01CA188430PubMed and NIHNIH RePORTER
R01 HD38572NICHD NIH HHSUnited StatesR01HD038572PubMed and NIHNIH RePORTER
K22 CA160725NCI NIH HHSUnited StatesK22CA160725PubMed and NIHNIH RePORTER
R01 HD038572NICHD NIH HHSUnited StatesR01HD038572PubMed and NIHNIH RePORTER
R01 CA063366NCI NIH HHSUnited StatesR01CA063366PubMed and NIHNIH RePORTER
R01 CA080991NCI NIH HHSUnited StatesR01CA080991PubMed and NIHNIH RePORTER
R01 CA113342NCI NIH HHSUnited StatesR01CA113342PubMed and NIHNIH RePORTER
P30 CA006927NCI NIH HHSUnited StatesP01CA006927PubMed and NIHNIH RePORTER
CA-06927NCI NIH HHSUnited StatesP01CA006927PubMed and NIHNIH RePORTER
P30CA006927NIHNIH RePORTER

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119309000Targeted disruption of Bcl-xL in mouse keratinocytes inhibits both UVB- and chemically induced skin carcinogenesis.Mol Carcinog2009https://conductscience.org/library/papers/19309000PubMed
224581497Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.Cell2014https://conductscience.org/library/papers/24581497PubMed
320037595Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses.Nat Med2010https://conductscience.org/library/papers/20037595PubMed
420048381Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.J Lipid Res2010https://conductscience.org/library/papers/20048381PubMed
520360469Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma.Blood2010https://conductscience.org/library/papers/20360469PubMed
620488992ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation.Science2010https://conductscience.org/library/papers/20488992PubMed
720696928Dysregulation of the mevalonate pathway promotes transformation.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20696928PubMed
823558541Steroidal triterpenes of cholesterol synthesis.Molecules2013https://conductscience.org/library/papers/23558541PubMed
923125191Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.Cancer Discov2013https://conductscience.org/library/papers/23125191PubMed
1024675946Cancer. Cholesterol and cancer, in the balance.Science2014https://conductscience.org/library/papers/24675946PubMed
1125651181Identification of natural RORγ ligands that regulate the development of lymphoid cells.Cell Metab2015https://conductscience.org/library/papers/25651181PubMed
1225652406Analysis of hedgehog signaling in cerebellar granule cell precursors in a conditional Nsdhl allele demonstrates an essential role for cholesterol in postnatal CNS development.Hum Mol Genet2015https://conductscience.org/library/papers/25652406PubMed
1322059152An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.Cancer Discov2011https://conductscience.org/library/papers/22059152PubMed
1411035776Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/11035776PubMed
1511172721A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.Mol Cell2001https://conductscience.org/library/papers/11172721PubMed
1611751630Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.Genes Dev2001https://conductscience.org/library/papers/11751630PubMed
1712966526Left-sided CHILD syndrome caused by a nonsense mutation in the NSDHL gene.Am J Med Genet A2003https://conductscience.org/library/papers/12966526PubMed
1814622593Lipid rafts: elusive or illusive?Cell2003https://conductscience.org/library/papers/14622593PubMed
1914726596EGF-like growth factors as mediators of LH action in the ovulatory follicle.Science2004https://conductscience.org/library/papers/14726596PubMed
2015093544Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.Cancer Cell2004https://conductscience.org/library/papers/15093544PubMed

See all 45 referencesDownload CSV of references

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
41952197NSDHL as a regulator of lipid peroxidation and ER stress-mediated apoptosis in ovarian cancer.Biol Direct2026https://conductscience.org/library/papers/41952197PubMed
41845506METTL16-mediated m6A modification of MSMO1 modulates cholesterol metabolism and activates MAPK-p38/NF-κB signaling in colorectal cancer.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/41845506PubMed
41782822MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway.iScience2026https://conductscience.org/library/papers/41782822PubMed
41437393USP43 promotes gemcitabine resistance by regulating cholesterol homeostasis through E2F1 stabilization in bladder cancer.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/41437393PubMed
41312741Liver X receptor: A potential target for inflammatory bowel disease and colorectal cancer (Review).Mol Med Rep2026https://conductscience.org/library/papers/41312741PubMed
40033501Integrated Bioinformatics Analysis Revealing that the NSDHL Gene Might Be Associated with the Progression of Western HFD/SW-Induced Hepatocellular CarcinomaEndocr Metab Immune Disord Drug Targets2026https://conductscience.org/library/papers/40033501PubMed
38896016The role of ATP-binding cassette subfamily G member 1 in tumor progression.Cancer Med2024https://conductscience.org/library/papers/38896016PubMed
38488003The cholesterol biosynthesis enzyme FAXDC2 couples Wnt/β-catenin to RTK/MAPK signaling.J Clin Invest2024https://conductscience.org/library/papers/38488003PubMed
37481560Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche.Cell Mol Biol Lett2023https://conductscience.org/library/papers/37481560PubMed
37441160IVM of human immature oocytes for infertility treatment and fertility preservation.Reprod Med Biol2023https://conductscience.org/library/papers/37441160PubMed
37059993Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.Breast Cancer Res2023https://conductscience.org/library/papers/37059993PubMed
37022791Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance.Antioxid Redox Signal2023https://conductscience.org/library/papers/37022791PubMed
36841765Prognosis-related molecular subtyping in head and neck squamous cell carcinoma patients based on glycolytic/cholesterogenic gene data.Cancer Cell Int2023https://conductscience.org/library/papers/36841765PubMed
36672209ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway.Cells2023https://conductscience.org/library/papers/36672209PubMed
36459180Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer.J Med Chem2022https://conductscience.org/library/papers/36459180PubMed
36381317CPSF1 positively regulates NSDHL by alternative polyadenylation and promotes gastric cancer progression.Am J Cancer Res2022https://conductscience.org/library/papers/36381317PubMed
35924232A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.Front Immunol2022https://conductscience.org/library/papers/35924232PubMed
35790992Lipid metabolism in tumor microenvironment: novel therapeutic targets.Cancer Cell Int2022https://conductscience.org/library/papers/35790992PubMed
35719918Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression.Front Oncol2022https://conductscience.org/library/papers/35719918PubMed
35050168Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma.Metabolites2022https://conductscience.org/library/papers/35050168PubMed

See all 55 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26344763

GET https://conductscience.org/api/papers/v1/26344763/references?page=2